Ultragenyx Pharmaceutical | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Acadia Pharmaceuticals USD 167.36M 167.35M 2025-06
Agios Pharmaceuticals USD 58.04M 57.96M 2025-06
Alnylam Pharmaceuticals USD 130.98M 129.67M 2025-06
BioMarin Pharmaceutical USD 192M 191.81M 2025-06
Insmed USD 211.11M 209.29M 2025-06
Ionis Pharmaceuticals USD 159.2M 159.04M 2025-06
Kyowa Hakko Kirin JPY 523.49M 26.22B 2025-06
MacroGenics USD 628K 1000 2024-12
Moderna USD 389M 388.96M 2025-06
Neurocrine Biosciences USD 99M 0 2025-06
PTC Therapeutics USD 79.38M 79.3M 2025-06
Regeneron Pharmaceuticals USD 106.4M 106.4M 2025-06
Sarepta Therapeutics USD 97.71M 97.7M 2025-06
Ultragenyx Pharmaceutical USD 96.35M 2.45M 2025-06
Vertex Pharmaceuticals USD 256.3M 253.7M 2025-06


Ultragenyx Pharmaceutical Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.